Key Takeaways
- • InTandem Capital Partners completed a strategic investment in Atlas Health, an AI-powered patient affordability platform, according to a Business Wire announcement dated October 29, 2026.
- • Atlas Health connects health systems to more than 7,000 funding sources to improve patient access, efficiency and affordability, per its company description.
- • Private equity coverage from PEI Private Equity characterized the transaction as a growth investment in Atlas Health.
- • The deal fits InTandem's stated strategy of backing small to mid-sized healthcare services companies, as described in the firm's own materials.
- • The original announcement's deal size, sellers and co-investors could not be verified from the available sources.
Summary
InTandem Capital Partners has completed a strategic investment in Atlas Health, according to a Business Wire announcement dated October 29, 2026. The release was carried in the same period by PEI Private Equity, which described the transaction as a growth investment in Atlas Health. The full press release could not be retrieved, so financial terms, valuation and the identity of any co-investors or sellers are not confirmed in the available material.
Atlas Health describes itself as an AI-powered platform for patient affordability. The company connects health systems to more than 7,000 funding sources with the stated aim of improving patient access, operational efficiency and affordability. Its positioning places it in the revenue-cycle and patient-financing segment of healthcare services, an area that has drawn growing private equity interest as providers seek tools to manage patient out-of-pocket obligations.
InTandem describes itself as a private equity firm that invests in and helps accelerate the growth of small to mid-sized companies in select healthcare services. The firm states it focuses on businesses aligned with the Healthcare Quintuple Aim, which emphasizes patient experience, provider experience, clinical outcomes, healthcare equity and lower cost of care. The Atlas investment is consistent with that mandate, although the firm's materials do not specify the size of this transaction.
InTandem has made similar healthcare services investments recently, including its completed investment in The Phia Group, a healthcare cost containment company, announced in a separate release. That transaction is a distinct event and is referenced here only for context on the firm's strategy.
Atlas Health describes itself as an AI-powered platform for patient affordability. The company connects health systems to more than 7,000 funding sources with the stated aim of improving patient access, operational efficiency and affordability. Its positioning places it in the revenue-cycle and patient-financing segment of healthcare services, an area that has drawn growing private equity interest as providers seek tools to manage patient out-of-pocket obligations.
InTandem describes itself as a private equity firm that invests in and helps accelerate the growth of small to mid-sized companies in select healthcare services. The firm states it focuses on businesses aligned with the Healthcare Quintuple Aim, which emphasizes patient experience, provider experience, clinical outcomes, healthcare equity and lower cost of care. The Atlas investment is consistent with that mandate, although the firm's materials do not specify the size of this transaction.
InTandem has made similar healthcare services investments recently, including its completed investment in The Phia Group, a healthcare cost containment company, announced in a separate release. That transaction is a distinct event and is referenced here only for context on the firm's strategy.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.